This seasoned medtech executive will advance Cynosure’s growth and innovation strategy and strengthen the company’s position as a leader in medical aesthetics technology.

WESTFORD, Mass., April 24, 2023 /PRNewswire/ — Cynosure, LLC (“Cynosure” or the “Company”), a leader in medical aesthetics systems and technologies, today announced that it has appointed Nadav Tomer, an accomplished executive of medical technology and former operating adviser to funds affiliated with Cynosure Clayton investor Dubilier

“Nadav has an incredibly strong track record of operational execution in the medtech space, and we are delighted to welcome him to Cynosure as CEO,” said Sandi Peterson, Cynosure’s Chairman of the Board. “Nadav brings decades of experience helping position global medtech companies for strong, profitable growth by advancing innovation, accelerating global commercialization, and working with research and development teams to unlock their full potential. This will be invaluable as we leverage the strength of the Cynosure team’s talent, global infrastructure, and differentiated technology to continue to bolster the company’s competitive advantage. I am confident Nadav is the right leader to guide Cynosure through its next chapter.” .

“I am excited to join Cynosure at such an important inflection point for the medical aesthetics industry,” said Tomer. “I have been following Cynosure for a long time and have been very impressed with its innovative offerings, its value proposition for its customers, and its world-class team. Each of these strengths is critical to long-term success and will help the company strengthen the reach and performance of its global platform. Most importantly, I look forward to joining a mission-driven company that is redefining how medical aesthetic technology can empower the patients it serves to feel their best” .

Peterson continued, “On behalf of the entire board, I would like to thank Todd for his leadership over the last three years. He has been instrumental in building the strong foundation from which Cynosure is operating today, and we are grateful for his contributions. We wish him To Todd the best in his future endeavors.”

About Nadav Tomer

Nadav Tomer brings to Cynosure more than 22 years of highly relevant leadership experience, having overseen global profit and loss and led growth, transformation and turnaround initiatives for numerous global medtech businesses. He has held senior leadership positions for a variety of Johnson’s global businesses.

Since May 2022, Tomer has been an operational advisor to funds affiliated with CD

Tomer currently serves on the boards of directors for Augmedics and Vascular Graft Solutions. She is a graduate of the Harvard Business School Advanced Management Program, has a B.S. in Medicine from Ben-Gurion University of the Negev, and has an M.B.A in Finance and Startups from Bar Ilan University.

About Cynosure

With over 30 years of history of science-driven innovation, Cynosure is a leading provider of aesthetic medical treatment systems that enable dermatologists, plastic surgeons, medical spas and other healthcare professionals to perform non-invasive and minimally invasive procedures. The company’s broad product portfolio spans several major categories, including skin revitalization, body contouring, and hair removal. Cynosure sells its products globally through a direct sales force in the United States, Canada, France, Morocco, Germany, Spain, the United Kingdom, Australia, China, Japan, and Korea, and through international distributors in approximately 130 other countries. . For corporate or product information, visit Cynosure’s website at

Logo –…

View original content: